BioSimilar BioSimilars: FDA Panel Overwhelming Recommends Approval of Remicade… Thomas Sullivan Feb 10, 2016 2 Yesterday an FDA Advisory panel overwhelmingly recommended the Celltrion/Pfizer biosimilar Remsima 21-3 for approval for…
